A Study on People’s Preferences for Pharmaceutical Company Creation after the Covid Epidemic in China: A Discrete Choice Experiment_Vol. 1 No. 1 (JMSD 2024)_Journal of Management and Social Development (ISSN: 3005-5741)

Home > Journal of Management and Social Development (ISSN: 3005-5741) > Vol. 1 No. 1 (JMSD 2024) >

A Study on People’s Preferences for Pharmaceutical Company Creation after the Covid Epidemic in China: A Discrete Choice Experiment

Download PDF

DOI: https://doi.org/10.62517/jmsd.202412106

Author(s)

Muhan Liu1,*, Guanrui Feng2, Zhang Sheng1

Affiliation(s)

1Department of Management, Hefei Technology School, Hefei, Anhui, China 2Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, Guangdong, China *Corresponding Author.

Abstract

The global healthcare industry has surged in significance in response to the COVID-19 pandemic, and China has actively incentivized entrepreneurial endeavors, including tax benefits. This study seeks to explore the preferences of individuals venturing into the healthcare sector in the post-pandemic landscape. Through convenience sampling we obtained valid data from 500 participants. Subsequently, we constructed logit and latent class models and conducted a subgroup analysis based on gender. The results indicated that: (1) the participants valued “Prospects of enterprise” and “Entrepreneurial team capabilities” the most, which was followed by “Available funds”; (2) participants were divided into five classes, with the largest number of participants in class 2, whose preference distribution approximates the distribution of the total participant population; (3) Male and female preferences differed in a way that was statistically significant; and (4) Class 2 had the highest leadership scores, while Class 5 scored higher on the “Agreeableness” of the Big Five-Factor Inventory than the other four factors. we underscores the importance of entrepreneurs adapting to changing societal needs and policymakers facilitating healthcare startups with increased funding and comprehensive training support.

Keywords

Discrete Choice Experiment; Big Five-Factor Inventory; Entrepreneurial Leadership; Big Health Industry; Post-epidemic Era

References

[1] Kobyatskaya, E. E., & Zhilina, T. N. (2021). The prospective directions of development of entrepreneurship in health care of the Russian Federation. Problems of Social Hygiene, Public Health and History of Medicine, 29(4), 856-860. [2] Dhainaut, J. F., Blin, O., Herry, F., Benito, S., Bilbault, P., Cauterman, M., & de Saint-Exupéry, E. (2020). Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?. Therapies, 75(1), 113-123. [3] Khalil, H., & Kynoch, K. (2021). Implementation of sustainable complex interventions in health care services: the triple C model. BMC Health Services Research, 21(1), 1-10. [4] Mas, J. P., & Hsueh, B. (2017). An investor perspective on forming and funding your medical device start-up. Techniques in vascular and interventional radiology, 20(2), 101-108. [5] Burton, M. D., Sørensen, J. B., & Dobrev, S. D. (2016). A careers perspective on entrepreneurship. Entrepreneurship Theory and Practice, 40(2), 237-247. [6] Huang, G. (2023). The implementation path of intelligent rehabilitation under the background of healthy China construction. Wearable Technology, 2(1), 41-50. [7] Langley, P. C. (2018). CVS Health and the imaginary worlds of the Institute for Clinical and Economic Review (ICER). Innovations in Pharmacy, 9(4). [8] Chakraborty, I., Ilavarasan, P. V., & Edirippulige, S. (2021). Health-tech startups in healthcare service delivery: A scoping review. Social Science & Medicine, 278, 113949. [9] Determann, D., Lambooij, M. S., Steyerberg, E. W., de Bekker-Grob, E. W., & De Wit, G. A. (2017). Impact of survey administration mode on the results of a health-related discrete choice experiment: online and paper comparison. Value in Health, 20(7), 953-960. [10] Soomro, B. A., Shah, N., & Mangi, S. (2018). Factors affecting the entrepreneurial leadership in small-and medium-sized enterprises (SMEs) of Pakistan: An empirical evidence. World Journal of Entrepreneurship, Management and Sustainable Development. [11] Gosling, S. D., Rentfrow, P. J., & Swann Jr, W. B. (2003). A very brief measure of the Big-Five personality domains. Journal of Research in personality, 37(6), 504-528. [12] Norman, R., Moorin, R., Maxwell, S., Robinson, S., & Brims, F. (2020). Public attitudes on lung cancer screening and radiation risk: A best-worst experiment. Value in Health, 23(4), 495-505. [13] Bliemer, M. C., & Rose, J. M. (2009). Efficiency and sample size requirements for stated choice experiments (No. 09-2421). [14] Hauber, A. B., González, J. M., Groothuis-Oudshoorn, C. G., Prior, T., Marshall, D. A., Cunningham, C., & Bridges, J. F. (2016). Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value in health, 19(4), 300-315. [15] Determann, D., Lambooij, M. S., Steyerberg, E. W., de Bekker-Grob, E. W., & De Wit, G. A. (2017). Impact of survey administration mode on the results of a health-related discrete choice experiment: online and paper comparison. Value in Health, 20(7), 953-960. [16] Greene, W. H., & Hensher, D. A. (2003). A latent class model for discrete choice analysis: contrasts with mixed logit. Transportation Research Part B: Methodological, 37(8), 681-698. [17] Lancsar, E., & Louviere, J. (2008). Conducting discrete choice experiments to inform healthcare decision making. Pharmacoeconomics, 26(8), 661-677. [18] Bridges, J. F., Hauber, A. B., Marshall, D., Lloyd, A., Prosser, L. A., Regier, D. A. & Mauskopf, J. (2011). Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value in health, 14(4), 403-413. [19] Lee, M., Park, S., & Lee, K. S. (2019). What are the features of successful medical device start-ups? Evidence from Korea. Sustainability, 11(7), 1948. [20] Tyebjee, T. T., & Bruno, A. V. (1984). A model of venture capitalist investment activity. Management science, 30(9), 1051-1066. [21] Chorev, S., & Anderson, A. R. (2006). Success in Israeli high-tech start-ups; Critical factors and process. Technovation, 26(2), 162-174. [22] Lei, J., Cao, N., Zhu, J., & Dai, Z. (2000, November). Innovation risks of hi-tech start-ups and the key factors to success. In Proceedings of the 2000 IEEE International Conference on Management of Innovation and Technology. ICMIT 2000.'Management in the 21st Century'(Cat. No. 00EX457) (Vol. 1, pp. 390-396). IEEE. [23] Peterson, R. A., Kozmetsky, G., & Ridgway, N. M. (1983). Perceived Causes of Small Business Failures: A Research Note. American Journal of Small Business, 8(1), 15–19. [24] Lussier, R. N. (1995). Startup business advice from business owners to would-be entrepreneurs. SAM Advanced Management Journal, 60(1), 10. [25] Groenewegen, G., & de Langen, F. (2012). Critical success factors of the survival of start-ups with a radical innovation. Journal of applied economics and business research, 2(3), 155-171. [26] Huang, S. Z., Lu, J. Y., Chau, K. Y., & Zeng, H. L. (2020). Influence of ambidextrous learning on eco-innovation performance of startups: moderating effect of top management’s environmental awareness. Frontiers in Psychology, 11, 1976. [27] Zhao, H., & Seibert, S. E. (2006). The big five personality dimensions and entrepreneurial status: a meta-analytical review. Journal of applied psychology, 91(2), 259. [28] Nicholson, N., Soane, E., Fenton‐O'Creevy, M., & Willman, P. (2005). Personality and domain‐specific risk taking. Journal of Risk Research, 8(2), 157-176.